GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SpectraScience Inc (GREY:SCIE) » Definitions » Cyclically Adjusted PB Ratio

SpectraScience (SpectraScience) Cyclically Adjusted PB Ratio : (As of Jun. 18, 2024)


View and export this data going back to . Start your Free Trial

What is SpectraScience Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


SpectraScience Cyclically Adjusted PB Ratio Historical Data

The historical data trend for SpectraScience's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SpectraScience Cyclically Adjusted PB Ratio Chart

SpectraScience Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SpectraScience Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SpectraScience's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, SpectraScience's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SpectraScience's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SpectraScience's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where SpectraScience's Cyclically Adjusted PB Ratio falls into.



SpectraScience Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

SpectraScience's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2017 is calculated as:

For example, SpectraScience's adjusted Book Value per Share data for the three months ended in Sep. 2017 was:

Adj_Book=Book Value per Share/CPI of Sep. 2017 (Change)*Current CPI (Sep. 2017)
=-0.003/104.1356*104.1356
=-0.003

Current CPI (Sep. 2017) = 104.1356.

SpectraScience Quarterly Data

Book Value per Share CPI Adj_Book
200712 0.153 88.616 0.180
200803 0.145 90.090 0.168
200806 0.129 92.320 0.146
200809 0.116 92.307 0.131
200812 0.099 88.697 0.116
200903 0.089 89.744 0.103
200906 0.086 91.003 0.098
200909 0.087 91.120 0.099
200912 0.106 91.111 0.121
201003 0.078 91.821 0.088
201006 0.092 91.962 0.104
201009 0.066 92.162 0.075
201012 0.062 92.474 0.070
201103 0.056 94.283 0.062
201106 0.048 95.235 0.052
201109 0.038 95.727 0.041
201112 0.023 95.213 0.025
201203 -0.005 96.783 -0.005
201206 -0.056 96.819 -0.060
201209 -0.025 97.633 -0.027
201212 -0.011 96.871 -0.012
201303 -0.025 98.209 -0.027
201306 -0.025 98.518 -0.026
201309 -0.022 98.790 -0.023
201312 -0.015 98.326 -0.016
201403 -0.032 99.695 -0.033
201406 -0.035 100.560 -0.036
201409 -0.026 100.428 -0.027
201412 -0.023 99.070 -0.024
201503 -0.030 99.621 -0.031
201506 -0.033 100.684 -0.034
201509 -0.033 100.392 -0.034
201512 -0.016 99.792 -0.017
201603 -0.013 100.470 -0.013
201606 -0.013 101.688 -0.013
201609 -0.013 101.861 -0.013
201612 -0.012 101.863 -0.012
201703 -0.008 102.862 -0.008
201706 -0.006 103.349 -0.006
201709 -0.003 104.136 -0.003

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SpectraScience  (GREY:SCIE) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


SpectraScience Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of SpectraScience's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SpectraScience (SpectraScience) Business Description

Traded in Other Exchanges
N/A
Address
11568-11 Sorrento Valley Road, San Diego, CA, USA, 92121
SpectraScience Inc is a US based company focused on developing the WavSTAT Optical Biopsy System (WavSTAT). The WavSTAT employs a risk technology that optically illuminates tissue in real-time to distinguish between normal and pre-cancerous or cancerous tissue. The firm has developed a technology platform to determine if the tissue is normal, pre-cancerous or cancerous, without the need for a physical biopsy. The WavSTAT operates by using cool, safe UV laser light to optically illuminate and analyze tissue, enabling the physician to make a diagnosis during endoscopy when screening for cancer and, if warranted, to begin treatment during the same procedure. The group sells its product in the United States and Europe, of which majority of the sales revenue is derived from the United States.
Executives
Lowell Giffhorn officer: CFO 10875 KEMAH LANE, SAN DIEGO CA 92131
John Pappajohn director 1660 WALT WHITMAN ROAD, SUITE 105, MELVILLE NY 11747
Euclidsr Partners, L.p. 10 percent owner 45 ROCKEFELLER PLAZA, SUITE 3240, NEW YORK NY 10111
Euclidsr Associates, L.p. 10 percent owner 45 ROCKEFELLER PLAZA, SUITE 3240, NEW YORK NY 10111
Tommy G Thompson director 7711 CARONDELET, ST. LOUIS MO 63105

SpectraScience (SpectraScience) Headlines

No Headlines